565 POSTER Activity of the anti-IGF-IR antibody CP-751,871 in combination with docetaxel as first-line treatment for castration resistant prostate cancer in a randomized Phase II trial

✍ Scribed by J.S. De Bono; D.P. Petrylak; E. Calvo; F. Saad; G.R. Hudes; M.M. Cooney; M.N. Pollak; D.B. Agus; S. Gillessen; J. Scranton

• Book ID: 119599721
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 69 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)72499-6